Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study. (Record no. 22674242)

MARC details
000 -LEADER
fixed length control field 02572 a2200697 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516144443.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201401s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1556-1380
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/JTO.0b013e31828cb505
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bylicki, Olivier
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20140123
245 00 - TITLE STATEMENT
Title Efficacy of pemetrexed as second-line therapy in advanced NSCLC after either treatment-free interval or maintenance therapy with gemcitabine or erlotinib in IFCT-GFPC 05-02 phase III study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Date of publication, distribution, etc. Jul 2013
300 ## - PHYSICAL DESCRIPTION
Extent 906-14 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenocarcinoma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Non-Small-Cell Lung
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Carcinoma, Squamous Cell
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Erlotinib Hydrochloride
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Glutamates
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Guanine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lung Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Staging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pemetrexed
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Quinazolines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Salvage Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemcitabine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ferlay, Céline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chouaid, Christos
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lavolé, Armelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Barlési, Fabrice
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dubos, Cathérine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Westeel, Virginie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Créquit, Jacky
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Corre, Roman
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vergnenègre, Alain
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Monnet, Isabelle
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Le Caer, Hervé
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fournel, Pierre
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vaylet, Fabien
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Falchero, Lionel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Poudenx, Michel
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Linard, Pauline
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pérol, David
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zalcman, Gérald
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pérol, Maurice
773 0# - HOST ITEM ENTRY
Title Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Related parts vol. 8
-- no. 7
-- p. 906-14
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/JTO.0b013e31828cb505">https://doi.org/10.1097/JTO.0b013e31828cb505</a>
Public note Available from publisher's website

No items available.